Skip to main content
Log in

Choice of marker for assessment of RV dysfunction in acute pulmonary embolism

NT-proBNP, pulmonary artery systolic pressure, mean arterial pressure, or blood pressure index

Wahl eines Parameters zur Beurteilung einer RV-Dysfunktion bei akuter Lungenembolie

NT-proBNP, pulmonalarterieller systolischer Druck, mittlerer arterieller Druck oder Blutdruckindex

  • Original articles
  • Published:
Herz Aims and scope Submit manuscript

Abstract

Background

We aimed to examine the value of NT-proBNP, pulmonary artery systolic pressure (PASP), blood pressure index (BPI), and mean arterial pressure (MAP) in the determination of right ventricular dysfunction (RVD) in patients with acute pulmonary embolism (APE).

Patients and methods

A total of 547 patients diagnosed with APE were included in the study. Demographic characteristics and comorbid conditions of patients were recorded in patient files. For blood pressure measurement, a calibrated digital blood pressure monitor was used at regular intervals. Blood samples were taken from patients at the time of admission for hemogram, biochemical, and hemostasis blood tests. Echocardiography was performed on all patients to detect RVD and evaluate pulmonary artery pressure.

Results

PASP (p < 0.001), MAP (p < 0.001), diastolic blood pressure (p < 0.001), D‑dimer (p = 0.001), NT-proBNP (p = 0.001), white blood cell (p < 0.001), and platelet (p = 0.001) counts were higher in APE patients with RVD compared with those without RVD, whereas the mean BPI level (p < 0.001) was lower. BPI had a negative correlation with PASP, NT-proBNP, platelet count, and triglyceride levels in patients with RVD. In regression analysis, BPI and PASP were found to be independent predictors of RVD. In receiver operating characteristic curve analysis, BPI (AUC ± SE = 0.975 ± 0.006; p < 0.001) was found to be the best predictor of RVD with a higher sensitivity (92.8%) and specificity (100%).

Conclusion

We found that BPI had a better diagnostic discrimination for RVD compared with PASP and NT-proBNP.

Zusammenfassung

Hintergrund

Ziel war es, die Überlegenheit von NT-proBNP, pulmonalarteriellem systolischem Druck (PASP), Blutdruckindex (BPI) oder mittlerem arteriellem Druck (MAP) zur Untersuchung einer rechtsventrikulären Dysfunktion (RVD) bei Patienten mit akuter Lungenembolie (APE) zu ermitteln.

Patienten und Methoden

Insgesamt wurden 547 Patienten mit APE in die Studie aufgenommen. Demographische Merkmale und Begleiterkrankungen der Patienten wurden in den Krankenakten dokumentiert. Zur Blutdruckmessung wurde in regelmäßigen Abständen ein kalibriertes digitales Blutdruckmessgerät verwendet. Bei Aufnahme ins Krankenhaus wurde den Patienten für ein Blutbild, biochemische und Gerinnungsparameter Blut entnommen. Eine Echokardiographie wurde bei allen Patienten durchgeführt, um ggf. eine RVD zu diagnostizieren und den pulmonalarteriellen Druck zu beurteilen.

Ergebnisse

PASP (p < 0,001), MAP (p < 0,001), diastolischer Blutdruck (p < 0,001), D‑Dimer (p = 0,001), NT-proBNP (p = 0,001), Leukozyten- (p < 0,001) und Thrombozytenzahl (p = 0,001) waren bei APE-Patienten mit RVD höher als bei Patienten ohne RVD, der mittlere BPI-Wert dagegen (p < 0,001) war niedriger. Der BPI wies eine negative Korrelation mit PASP, NT-proBNP, Thrombozytenzahl und Triglyzeridwerten bei Patienten mit RVD auf. In der Regressionsanalyse stellten sich BPI und PASP als unabhängige Prädiktoren einer RVD heraus. In der Receiver-Operating-Characteristic-Curve-Analyse erwies sich der BPI (Fläche unter der Kurve ± Standardfehler, AUC ± SE = 0,975 ± 0,006; p < 0,001) mit einer höheren Sensitivität (92,8%) und Spezifität (100%) als der beste Prädiktor einer RVD.

Schlussfolgerung

Die Autoren stellten fest, dass der BPI sich besser zur diagnostischen Abgrenzung einer RVD eignet als PASP und NT-proBNP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Silverstein MD, Heit JA, Mohr DN et al (1998) Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 158(6):585–593

    Article  CAS  PubMed  Google Scholar 

  2. Cho JH, Kutti Sridharan G, Kim SH et al (2014) Right ventricular dysfunction as an echocardiographic prognostic factor in hemodynamically stable patients with acute pulmonary embolism: a meta-analysis. BMC Cardiovasc Disord 14:64

    Article  PubMed  PubMed Central  Google Scholar 

  3. Kucher N, Rossi E, De Rosa M, Goldhaber SZ (2006) Massive pulmonary embolism. Circulation 113(4):577–582

    Article  PubMed  Google Scholar 

  4. Alpert JS, Smith R, Carlson J et al (1976) Mortality in patients treated for pulmonary embolism. JAMA 236(13):1477–1480

    Article  CAS  PubMed  Google Scholar 

  5. Grifoni S, Olivotto I, Cecchini P et al (2000) Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation 101(24):2817–2822

    Article  CAS  PubMed  Google Scholar 

  6. Meyer T, Binder L, Hruska N et al (2000) Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction. J Am Coll Cardiol 36(5):1632–1636

    Article  CAS  PubMed  Google Scholar 

  7. Pieralli F, Olivotto I, Vanni S et al (2006) Usefulness of bedside testing for brain natriuretic peptide to identify right ventricular dysfunction and outcome in normotensive patients with acute pulmonary embolism. Am J Cardiol 97(9):1386–1390

    Article  CAS  PubMed  Google Scholar 

  8. Dursunoglu N, Dursunoglu D, Yildiz AI, Rota S (2016) Evaluation of cardiac biomarkers and right ventricular dysfunction in patients with acute pulmonary embolism. Anatol J Cardiol 16(4):276–282

    PubMed  Google Scholar 

  9. Coutance G, Cauderlier E, Ehtisham J et al (2011) The prognostic value of markers of right ventricular dysfunction in pulmonary embolism: a meta-analysis. Crit Care 15(2):R103

    Article  PubMed  PubMed Central  Google Scholar 

  10. Torbicki A, Perrier A, Konstantinides S et al (2008) Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 29(18):2276–2315

    Article  CAS  PubMed  Google Scholar 

  11. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18(6):499–502

    CAS  PubMed  Google Scholar 

  12. O’Brien E, Atkins N, Stergiou G et al (2010) European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults. Blood Press Monit 15(1):23–38

    Article  PubMed  Google Scholar 

  13. Ates H, Ates I, Bozkurt B et al (2016) What is the most reliable marker in the differential diagnosis of pulmonary embolism and community-acquired pneumonia? Blood Coagul Fibrinolysis 27(3):252–258

    Article  CAS  PubMed  Google Scholar 

  14. Sakaki K, Nie M, Sasahara A et al (2016) Emergency surgery for acute pulmonary embolism. Kyobu Geka 69(3):197–200

    PubMed  Google Scholar 

  15. Henzler T, Roeger S, Meyer M et al (2012) Pulmonary embolism: CT signs and cardiac biomarkers for predicting right ventricular dysfunction. Eur Respir J 39(4):919–926

    Article  CAS  PubMed  Google Scholar 

  16. Wong LF, Akram AR, McGurk S et al (2012) Thrombus load and acute right ventricular failure in pulmonary embolism: correlation and demonstration of a “tipping point” on CT pulmonary angiography. Br J Radiol 85(1019):1471–1476

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Abul Y, Ozsu S, Karakurt S et al (2013) Prediction of right ventricular dysfunction from radiographic estimates of right descending pulmonary artery in hemodynamically stable pulmonary embolism patients. Cardiol J 20(2):184–189

    Article  PubMed  Google Scholar 

  18. Staskiewicz G, Czekajska-Chehab E, Uhlig S et al (2013) Logistic regression model for identification of right ventricular dysfunction in patients with acute pulmonary embolism by means of computed tomography. Eur J Radiol 82(8):1236–1239

    Article  PubMed  Google Scholar 

  19. Graner M, Harjola VP, Selander T et al (2016) N‑terminal pro-brain natriuretic peptide, high-sensitivity troponin and pulmonary artery clot score as predictors of right ventricular dysfunction in echocardiography. Heart Lung Circ 25(6):592–599

    Article  PubMed  Google Scholar 

  20. Rodrigues AC, Cordovil A, Monaco C et al (2013) Right ventricular assessment by Tissue-Doppler echocardiography in acute pulmonary embolism. Arq Bras Cardiol 100(6):524–530

    PubMed  Google Scholar 

  21. Varol K, Gumus C, Yucel H et al (2015) Correlation of right ventricular dysfunction on acute pulmonary embolism with pulmonary artery computed tomography obstruction index ratio (PACTOIR) and comparison with echocardiography. Jpn J Radiol 33(6):311–316

    Article  PubMed  Google Scholar 

  22. Praveen Kumar BS, Rajasekhar D, Vanajakshamma V (2014) Study of clinical, radiological and echocardiographic features and correlation of Qanadli CT index with RV dysfunction and outcomes in pulmonary embolism. Indian Heart J 66(6):629–634

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Aribas A, Keskin S, Akilli H et al (2014) The use of axial diameters and CT obstruction scores for determining echocardiographic right ventricular dysfunction in patients with acute pulmonary embolism. Jpn J Radiol 32(8):451–460

    Article  PubMed  Google Scholar 

  24. Ates I, Bulut M, Ozkayar N, Dede F (2015) Association between high platelet indices and proteinuria in patients with hypertension. Ann Lab Med 35(6):630–634

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Mebazaa A, Karpati P, Renaud E, Algotsson L (2004) Acute right ventricular failure – from pathophysiology to new treatments. Intensive Care Med 30(2):185–196

    Article  PubMed  Google Scholar 

  26. Chin KM, Kim NH, Rubin LJ (2005) The right ventricle in pulmonary hypertension. Coron Artery Dis 16(1):13–18

    Article  PubMed  Google Scholar 

  27. Matthews JC, McLaughlin V (2008) Acute right ventricular failure in the setting of acute pulmonary embolism or chronic pulmonary hypertension: a detailed review of the pathophysiology, diagnosis, and management. Curr Cardiol Rev 4(1):49–59

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. Ates MD.

Ethics declarations

Conflict of interest

H. Ates, I. Ates, H. Kundi, and F.M. Yilmaz declare that they have no competing interests.

The present study was designed in accordance with the Helsinki Declaration. It was approved by the local Ethics Board and Research Committee. Written consent was obtained from all participants included in the study.

Additional information

Author contribution. H. Ates, I. Ates, H. Kundi, and F.M. Yilmaz designed the research. I. Ates and F.M. Yilmaz analyzed the data. H. Ates and I. Ates wrote the paper. All authors take responsibility for the interpretation of data and critical revision of the manuscript for important intellectual content. H. Ates takes full responsibility for the integrity of the data and analyses.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ates, H., Ates, I., Kundi, H. et al. Choice of marker for assessment of RV dysfunction in acute pulmonary embolism. Herz 42, 758–765 (2017). https://doi.org/10.1007/s00059-016-4513-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00059-016-4513-6

Keywords

Schlüsselwörter

Navigation